Table 2.

Adjusted odds ratios for the use of antihistamines and anti-inflammatory agents among glioma cases and controls, Harris County Adult Glioma Study, 2001-2006

Controls (n = 600)Cases (n = 325)Odds ratio (95% CI)
Antihistamine use
    Yes92421.37 (0.87, 2.14)
    No508278Reference
Anti-inflammatory use
    Yes188720.67 (0.47, 0.96)
    No412248Reference
History of asthma or allergy
    Yes202440.34 (0.23, 0.51)
    No398276Reference
History of chickenpox
    Yes5152360.52 (0.36, 0.75)
    No8584Reference
History of oral herpes
    Yes76100.28 (0.14, 0.57)
    No524310Reference
History of mononucleosis
    Yes65130.40 (0.21, 0.76)
    No535307Reference
History of migraine headaches
    Yes5040.19 (0.07, 0.54)
    No550316Reference
Previous head injury
    Yes1841151.41 (1.03, 1.93)
    No416205Reference
  • NOTE: The odds ratios were derived from unconditional logistic regression models, adjusting for age, gender, and race, and controlling for all other covariates.